{
    "clinical_study": {
        "@rank": "136136", 
        "acronym": "KorHR", 
        "arm_group": {
            "arm_group_label": "incident hypertensives", 
            "description": "Inclusion Criteria:\nage\u226730years\nprimary incident hypertension\nsigned informed consent"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to know prevalence of clinical or subclinical target organ\n      damages in Korea hypertensives by constructing nationwide hypertension registry. We will\n      register 5000 consecutive patients with incident hypertension at 20 major university\n      hospitals in South Korea. We will investigate clinical/subclinical target organ damages,\n      renin/aldosterone level and cardiovascular events in each patient."
        }, 
        "brief_title": "Korean Registry of Target Organ Damages in Hypertension", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "Background: the exact prevalence of target organ damages in Korean hypertensives are\n      unknown.\n\n      Study Objective: to investigate the prevalence of target organ damages in Korean patients\n      with incident hypertension.\n\n      Study Design: prospective, multi-center and observational study\n\n      Study Populaton: approximately 5000 consecutive patients with incident hypertension, who\n      visited outpatients clinics and agreed to participate in the registry\n\n      Primary outcome\n\n        -  Subclinical organ damages\n\n             1. left ventricular hypertrophy on electrocardiogram or echocardiography\n\n             2. increased intima media thickness of carotid artery (> 0.9 mm) or plaque\n\n             3. increased pulse wave velocity (> 12 m/s)\n\n             4. low estimated glomerular filtration rate (< 60 ml/min/1.73 m2) or creatinine\n                clearance (<60 ml/min)\n\n        -  Established CV or renal disease\n\n             1. cerebrovascular disease: ischemic stroke; cerebral stroke; transient ischemic\n                attack\n\n             2. Heart disease: myocardial infarction; angina; coronary revascularization; heart\n                failure\n\n             3. Renal disease: diabetic retinopathy; serum creatinine M > 133, W > 124 mmol/L;\n                proteinuria > 300 mg/24 hr\n\n             4. Peripheral artery disease\n\n             5. Advanced retinopathy: hemorrhage or exudates, papilledema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age\u226730years\n\n          -  primary incident hypertension\n\n          -  singed informed consent\n\n        Exclusion Criteria:\n\n          -  participated in other clinical trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "30 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Korean patients with incident hypertensive, who visited university hospital"
            }
        }, 
        "enrollment": {
            "#text": "5000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01861080", 
            "org_study_id": "2012-005"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "target organ damage", 
            "incident hypertension", 
            "cohort"
        ], 
        "lastchanged_date": "May 21, 2013", 
        "location": {
            "contact": {
                "email": "khryumd@hanmail.net", 
                "last_name": "Kyu-Hyung Ryu, MD, PhD", 
                "phone": "+82-31-8086-2827"
            }, 
            "contact_backup": {
                "email": "swchoi97@gmail.com", 
                "last_name": "Suk-Won Choi, MD", 
                "phone": "+82-31-8086-2538"
            }, 
            "facility": {
                "address": {
                    "city": "Hwaseong", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggido", 
                    "zip": "445-170"
                }, 
                "name": "Hallym University Dongtan Sacred Heart Hospital,"
            }, 
            "investigator": {
                "last_name": "Kyu-Hyung Ryu, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "Observational Study of Clinical Characteristics and Prognostic Factors of Korean Hypertensives", 
        "other_outcome": {
            "description": "death, stroke, myocardial infarction and heart failure(confirmed by a cardiologist)", 
            "measure": "major cardiovascular events", 
            "safety_issue": "Yes", 
            "time_frame": "after follow-up period of 36 months"
        }, 
        "overall_contact": {
            "email": "khryumd@hanmail.net", 
            "last_name": "Kyu-Hyung Ryu, MD, PhD", 
            "phone": "+82-31-8086-2827"
        }, 
        "overall_contact_backup": {
            "email": "swchoi97@gmail.com", 
            "last_name": "Suk-Won Choi, MD", 
            "phone": "+82-31-8086-2541"
        }, 
        "overall_official": {
            "affiliation": "Dongtan Sacred Heart Hospital, Hallym University", 
            "last_name": "Kyu-Hyung Ryu, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "left ventricular hypertrophy on electrocardiogram or echocardiography Sokolow-Lyon > 38 mm; left ventricular mass index male >= 125 g/m2, female >=110 g/m2)", 
                "measure": "left ventricular hypertrophy", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "increased intima media thickness of carotid artery (> 0.9 mm) or presence of plaque", 
                "measure": "Intima media thickness of carotid artery", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "increased pulse wave velocity (> 12 m/s)", 
                "measure": "pulse wave velocity", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "low estimated glomerular filtration rate (< 60 ml/min/1.73 m2) or creatinine clearance (< 60 ml/min)", 
                "measure": "kidney function", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "ischemic stroke, cerebral hemorrhage, or transient ischemic attack confirmed by a neurologist", 
                "measure": "cerebrovascular accident", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "serum creatinine male > 1.5 mg/dl, female > 1.4 mg/dl; proteinuria > 300 mg/24hr", 
                "measure": "renal disease", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "ankle to brachial blood pressure ratio < 0.9", 
                "measure": "peripheral artery disease", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "retinal hemorrhage or exudate, papilledema confirmed by an ophthalmologist", 
                "measure": "retinopathy", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01861080"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dongtan Sacred Heart Hospital", 
            "investigator_full_name": "Suk Won Choi", 
            "investigator_title": "Kyu-Hyung Ryu, M.D., Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "high blood pressure confirmed by ambulatory blood pressure monitoring (24hr average systolic blood pressure >=135 mm Hg, diastolic blood pressure >= 85 mm Hg", 
                "measure": "Hypertension", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "total cholesterol 190 mg/dl or LDL > 115 mg/dl, HDL male < 40 mg/dl, female < 46 mg/dl or triglyceride > 150 mg/dl", 
                "measure": "Dyslipidemia", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "abnormal fasting plasma glucose (102-125 mg/dl)", 
                "measure": "abnormal fasting plasma glucose", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "waist circumference male > 102 cm, female > 88 cm", 
                "measure": "abdominal obesity", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }, 
            {
                "description": "fasting plasma glucose >= 126 mg/dl; postload plasma glucose > 198 mg/dl", 
                "measure": "diabetes mellitus", 
                "safety_issue": "Yes", 
                "time_frame": "at enrollment"
            }
        ], 
        "source": "Dongtan Sacred Heart Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dongtan Sacred Heart Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "36 Months", 
        "verification_date": "May 2013"
    }
}